The ELR<sup>+</sup>CXCL chemokines and their receptors CXCR1/CXCR2: A signaling axis and new target for the treatment of renal cell carcinoma.

Giuliano, Sandy; Guyot, Mélanie; Grépin, Renaud; Pagès, Gilles

The ELR⁺CXCL chemokines and their receptors CXCR1/CXCR2: A signaling axis and new target for the treatment of renal cell carcinoma.

Giuliano, Sandy; Guyot, Mélanie; Grépin, Renaud; Pagès, Gilles.

Afiliación

Giuliano S; University of Nice Sophia Antipolis; UMR CNRS 7284/U INSERM 1081; Nice, France.
Guyot M; University of Nice Sophia Antipolis; UMR CNRS 7284/U INSERM 1081; Nice, France.
Grépin R; Centre Scientifique de Monaco; Monaco.
Pagès G; University of Nice Sophia Antipolis; UMR CNRS 7284/U INSERM 1081; Nice, France.

Oncoimmunology ; 3: e28399, 2014.

Article en En | MEDLINE | ID: mdl-25050209

Palabras clave

CXCL7; CXCR1; CXCR2; ELR+CXCL; angiogenesis; inflammation; renal cell carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2014 Tipo del documento: Article País de afiliación: Francia